EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Advancing cancer detection and treatment using longitudinal routine clinical data

Fei Liu, Kai Wang, Hui Xu, Cheng Tang, Xian Shen, Meihao Wang, Lei Yang, Li Yang, Li Liu, Changxi Hu, Gen Li, Wei Wu und 31 weitere

Cell · 2026-09 · 189 (19) · 5995-6011.e8

DOI: 10.1016/j.cell.2026.07.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-09. Verfasst von Fei Liu und 42 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Data Science Institute, State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, and The Zhejiang Key Laboratory of Intel…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer management remains fragmented across its continuum, from late-stage diagnosis and salvage therapies to non-personalized surveillance. Here, we present Oncoformer, a unified multimodal transformer model trained on the China Oncology Multimodal Prediction and Surveillance Study (COMPASS) cohort (3.67 million individuals, 17.7 million clinical visits) and validated on independent external cohorts, including the UK Biobank. Oncoformer integrates longitudinal electronic health records with chest X-ray imaging to address multiple clinical tasks: pan-cancer diagnosis (area under the receiver operating characteristic curve [AUROC] = 0.956), future cancer prediction up to 1 year before diagnosis (AUROC = 0.869), tumor stage inference (mean AUROC > 0.90), patient-specific treatment-response forecasting, and recurrence-free survival stratification across ten cancer types (all p < 0.01). Staging predictions were independently validated against postoperative pathological endpoints and shown to converge on core cancer genomic pathways. By translating routine clinical data into a dynamic view of cancer evolution, Oncoformer provides a framework for risk-informed cancer prediction and treatment stratification using routine clinical data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansElectronic Health RecordsPrecision MedicineNeoplasm StagingFemaleLongitudinal StudiesROC CurvePrognosisMale

Stichwörter der Autor:innen

cancer predictiondeep learningelectronic health recordsmultimodal data fusionpersonalized medicine

Autor:innen und Institutionen

  • Clinical Data Science Institute, State Key Laboratory of Macromolecular Drugs and Large-scale Manufacturing, and The Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, the First Affiliate…
  • Artificial Intelligence Cross Disciplinary Research Institute, Faculty of Medicine, Macau University of Science and Technology, Macau, China; State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University,…
  • Department of Radiology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Key Laboratory of Intelligent Medical Imaging of Wenzhou, Healthcare Center, The First Affiliated Hospital of Wenzho…
  • Department of Orthopedics, Key Laboratory of Hepatosplenic Surgery of Ministry of Education, the First Affiliated Hospital, Harbin Medical University, Harbin, China.
  • Department of Respiratory and Critical Care Medicine, Center for Big Data and Intelligent Medicine, the First Affiliated Hospital of Chongqing Medical University, Key Laboratory of Digital Health and Intelligent Medicin…
  • Department of Health Management, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Liu, F., Wang, K., Xu, H., Tang, C., Shen, X., Wang, M., Yang, L., Yang, L., Liu, L., Hu, C., Li, G., Wu, W., Zou, Z., Li, B., Liu, S., Kang, J., Kong, J., Li, T., Wong, I. N., …, & International Consortium of Digital Twins in Healthcare and Medicine (2026). Advancing cancer detection and treatment using longitudinal routine clinical data. Cell, 189(19), 5995-6011.e8. https://doi.org/10.1016/j.cell.2026.07.009

Vancouver

Liu F, Wang K, Xu H, Tang C, Shen X, Wang M, et al. Advancing cancer detection and treatment using longitudinal routine clinical data. Cell. 2026;189(19):5995-6011.e8. doi:10.1016/j.cell.2026.07.009

BibTeX
@article{Liu2026,
  author = {Liu, Fei and Wang, Kai and Xu, Hui and Tang, Cheng and Shen, Xian and Wang, Meihao and Yang, Lei and Yang, Li and Liu, Li and Hu, Changxi and Li, Gen and Wu, Wei and Zou, Zixing and Li, Bingzhou and Liu, Sian and Kang, Jin and Kong, Jungho and Li, Ting and Wong, Io Nam and Huang, Xiaoying and Chen, Gang and Lu, Wenyang and Ziyar, Ian and Zhang, Charlotte L and Sun, Yiwen and Lin, Weihong and Ou, Caiwen and Fok, Manson and Hou, Taiwa and Wang, Winston and Xue, Kanmin and Yin, Yun and Zhu, Hao and Gootenberg, Jonathan and Abudayyeh, Omar O and Karin, Michael and Loupy, Alexandre and Rasko, John E J and Ideker, Trey and Luo, Huiyan and Oermann, Eric and Zhang, Kang and International Consortium of Digital Twins in Healthcare and Medicine, International Consortium of Digital Twins in Healthcare and Medicine},
  title = {Advancing cancer detection and treatment using longitudinal routine clinical data},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {19},
  pages = {5995--6011.e8},
  doi = {10.1016/j.cell.2026.07.009}
}
Kostenlos starten →